Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:


Guest: Welcome to ChinaBio
® Today!

As a guest to ChinaBio® Today, you have access to summaries of over 3000 articles including our archives.  You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.   

Top Stories

>> See all top stories...

Recent Articles

Recent Articles

  Week in Review: Cathay Fortune Pays $186 Million for German Diagnostic Company (in: Week in Review)
  Digital China Joins State-Owned Enterprises for Big Data Healthcare (in: Deals & Financings)
  Bristol-Myers Squibb's Oral, Interferon-free HCV Regimen Approved in China (in: Trials & Approvals)
  Cathay Fortune to Acquire Germany's Epigenomics for $186 Million (in: Deals & Financings)
  China's BGI and Healthlink Invest and Make Deal with UK's Congenica (in: Deals & Financings)
  Aslan Officially Announces $40 Million Taiwan IPO (in: Deals & Financings)
  Shanghai's EpimAb Closes $25 Million A Round for Bi-Specifics (in: Deals & Financings)
  Aslan to Start Global Phase III Trial of Lead Cancer Drug (in: Trials & Approvals)
  Zai Lab Acquires China Rights to Novel Antibiotic from Paratek (in: Deals & Financings)
  HitGen Enters Drug Discovery Collaboration with Scripps Research Institute (in: Deals & Financings)